MarketInOut Stock Screener Log In | Sign Up

Fortress Biotech Inc 9.375 Cum. Pfd Series A

NASDAQ • Healthcare • Biotechnology • Quote as of 10/28/2026 16:00
Fortress Biotech Inc 9.375 Cum. Pfd Series A stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization61.56 mln
Float21.44 mln
Earnings Date08/15/2025

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.26
Very low leverage

Pre-Tax Margin

213%
Exceptional margin

ROE

116
Extraordinary

ROA

-7.76
Negative

Business Description

Fortress Biotech is a Florida-based drug development company focused on bringing new treatments to market across a range of medical conditions. Its most established business centers on skin care, with a portfolio of prescription products addressing acne, rosacea, excessive sweating, fungal infections, and wound care. Beyond dermatology, the company is advancing a broad pipeline of treatments targeting cancer, rare diseases, pain management, and viral infections at various stages of development. Founded in 2006, Fortress operates both directly and through a network of subsidiary companies, each focused on specific therapeutic areas.

Key Fundamentals

EPS-0.86
ROE116
RPS2.25
ROIC-10.85
ROA-7.76
Interest Cover-3.27
EBITDA, mln-24.98
EV / EBITDA-17.57
Revenue, mln68.47
EV / Revenue6.41

Quote Details

Last 15.87
Change -0.14 (-0.87%)
Open 16.01
Volume 24,783
Turnover 393,306
Average Volume 11,277

Financial Ratios

Pre-Tax Profit Margin213
Leverage Ratio1.93
Current Ratio3.96
Price / Book3.25
Price / Cash Flow0.48
Price / Free Cash Flow0.51
Debt / Equity0.26
Price / Sales0.93

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.37% 13 / 100   
1 Month -4.8% 34 / 100   
2 Months -15.81% 24 / 100   
6 Months 10.06% 80 / 100   
1 Year 126% 98 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog